In the news

Boston Scientific signed a virtual power purchase agreement (VPPA) for 42 megawatts of solar power and subscribed to a 12.9-MW community solar portfolio.

At Boston Scientific, their priority has been to protect and aid the health and safety of their employees, their physician customers, and their patients.

The Coventor, developed by a team of engineers and medical school faculty at the University of Minnesota, works in a similar way but will cost roughly $1,000 to produce. Boston Scientific plans to begin manufacturing the devices and selling them at cost.

Boston Scientific, with the FDA's quick OK, will start production in Maple Grove in a month or so.

After several months of voting and a live pitch-off at Google’s campus, Boston Scientific announced the winners of its fifth annual Connected Patient Challenge.

“Many people define success in monetary terms; but I think a true definition of success means more than that,” said David Pierce is executive vice president and president, MedSurg, at Boston Scientific.

Following several acquisitions of European companies, US-based medical manufacturer Boston Scientific has issued its first batch of euro-denominated bonds. David Wigan reports.

For the fifth year in a row, Boston Scientific is recognized on Fortune’s list of the World’s Most Admired Companies, ranking in the top 100 overall.